Mark W. Kroll
Director · HAEMONETICS CORP
IndividualBuying only
- 2025
- Jul 28, 2026
- 3
Filings (90d)
1
Other insiders active in the same sector
No other insider has filed at Mark W. Kroll's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark W. Kroll?
Mark W. Kroll is a corporate insider, tracked as Director of HAEMONETICS CORP (HAE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark W. Kroll submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mark W. Kroll been buying or selling stock?
Recorded transactions: 1 open-market purchase ($99K) and 0 open-market sales across all tracked filings.
